Caremark Sees Competitive Upside From Hemophilia Product Shortage
Executive Summary
Caremark Therapeutic Systems sees a long-term growth opportunity from the shortage of recombinant Factor VIII products, Caremark Rx CEO Mac Crawford said during a June 5 analysts meeting at the company's mail order pharmacy in Mount Prospect, Ill.